|
DNAJC11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.97080000003047E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.50451999999524E-05 |
| Normal-vs-Stage2 |
1.63620000004361E-06 |
| Normal-vs-Stage3 |
1.8902999999737E-06 |
| Normal-vs-Stage4 |
3.89260000011049E-07 |
| Stage1-vs-Stage2 |
2.534200E-01 |
| Stage1-vs-Stage3 |
2.356600E-01 |
| Stage1-vs-Stage4 |
7.530300E-02 |
| Stage2-vs-Stage3 |
9.514000E-01 |
| Stage2-vs-Stage4 |
3.342400E-01 |
| Stage3-vs-Stage4 |
3.879000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.21329999997122E-06 |
| Normal-vs-AfricanAmerican |
2.01039999999653E-05 |
| Normal-vs-Asian |
9.6589999999952E-05 |
| Caucasian-vs-AfricanAmerican |
2.482200E-01 |
| Caucasian-vs-Asian |
7.668600E-01 |
| AfricanAmerican-vs-Asian |
5.578000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.02720000000534E-06 |
| Normal-vs-Female |
1.93120999999463E-05 |
| Male-vs-Female |
1.196770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.51714999999664E-05 |
| Normal-vs-Extreme_Weight |
1.99619999996514E-06 |
| Normal-vs-Obese |
4.45849999997083E-06 |
| Normal-vs-Extreme_Obese |
2.358100E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.182400E-01 |
| Normal_Weight-vs-Obese |
9.308400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.407200E-01 |
| Extreme_Weight-vs-Obese |
2.997400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.243000E-01 |
| Obese-vs-Extreme_Obese |
3.248800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.95780000003631E-06 |
| Normal-vs-Age(41-60Yrs) |
4.27319999996012E-06 |
| Normal-vs-Age(61-80Yrs) |
4.74399999994546E-06 |
| Normal-vs-Age(81-100Yrs) |
3.45609999952146E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.906400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.142800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.306300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.316800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.957200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.779000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.7372000000202E-06 |
| Normal-VS-Type2 PRCC |
3.97279999997391E-06 |
| Normal-VS-KIRP CIMP |
1.09829999983546E-07 |
| Normal-VS-Unclassified PRCC |
2.026799999999E-05 |
| Type1 PRCC-VS-Type2 PRCC |
9.832600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.478400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.679000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.155240E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.612400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.449100E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.48129999999469E-06 |
| Normal-vs-N1 |
7.50360000023598E-07 |
| Normal-vs-N2 |
1.15650000021006E-07 |
| N0-vs-N1 |
4.013800E-01 |
| N0-vs-N2 |
1.023190E-01 |
| N1-vs-N2 |
2.889600E-01 |
|
|
